COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Loss and Damage Negotiations in Overdrive; Right to ‘Healthy Environment’ Drops Out 19/11/2022 Elaine Ruth Fletcher & Stefan Anderson SHARM EL SHEIKH, EGYPT – Michael Terungwa, a solar entrepreneur in Abuja, Nigeria, will know that real progress is being made on climate change when things change in his hometown. When the 10-20% in customs and tariffs that he pays for cheap, imported Chinese solar panels are removed; when his customers’ solar purchases are subsidized […] Continue reading -> The Double-Edged Sword of the Digital Health Transformation 15/11/2022 Maayan Hoffman New report highlights the impact of social media on the health of young people in middle- and low-income countries. The digital transformation of health offers both significant empowerment potential and significant risks for young people, according to a new study published Tuesday by the Global Health Centre of the Graduate Institute of International and Development […] Continue reading -> The Niger Delta’s Harsh Lessons: Fossil Fuels’ Harm to People and the Planet 13/11/2022 Elaine Ruth Fletcher SHARM EL SHEIKH, EGYPT – Ken Henshaw’s story of his Niger Delta community’s experience with fossil fuel extraction reads like the fallout from a war zone without the ready presence of international media to document the devastation. Henshaw lives at ground zero of one of Africa’s earliest and longest-running experiences with oil extraction, a six […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Loss and Damage Negotiations in Overdrive; Right to ‘Healthy Environment’ Drops Out 19/11/2022 Elaine Ruth Fletcher & Stefan Anderson SHARM EL SHEIKH, EGYPT – Michael Terungwa, a solar entrepreneur in Abuja, Nigeria, will know that real progress is being made on climate change when things change in his hometown. When the 10-20% in customs and tariffs that he pays for cheap, imported Chinese solar panels are removed; when his customers’ solar purchases are subsidized […] Continue reading -> The Double-Edged Sword of the Digital Health Transformation 15/11/2022 Maayan Hoffman New report highlights the impact of social media on the health of young people in middle- and low-income countries. The digital transformation of health offers both significant empowerment potential and significant risks for young people, according to a new study published Tuesday by the Global Health Centre of the Graduate Institute of International and Development […] Continue reading -> The Niger Delta’s Harsh Lessons: Fossil Fuels’ Harm to People and the Planet 13/11/2022 Elaine Ruth Fletcher SHARM EL SHEIKH, EGYPT – Ken Henshaw’s story of his Niger Delta community’s experience with fossil fuel extraction reads like the fallout from a war zone without the ready presence of international media to document the devastation. Henshaw lives at ground zero of one of Africa’s earliest and longest-running experiences with oil extraction, a six […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Double-Edged Sword of the Digital Health Transformation 15/11/2022 Maayan Hoffman New report highlights the impact of social media on the health of young people in middle- and low-income countries. The digital transformation of health offers both significant empowerment potential and significant risks for young people, according to a new study published Tuesday by the Global Health Centre of the Graduate Institute of International and Development […] Continue reading -> The Niger Delta’s Harsh Lessons: Fossil Fuels’ Harm to People and the Planet 13/11/2022 Elaine Ruth Fletcher SHARM EL SHEIKH, EGYPT – Ken Henshaw’s story of his Niger Delta community’s experience with fossil fuel extraction reads like the fallout from a war zone without the ready presence of international media to document the devastation. Henshaw lives at ground zero of one of Africa’s earliest and longest-running experiences with oil extraction, a six […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Niger Delta’s Harsh Lessons: Fossil Fuels’ Harm to People and the Planet 13/11/2022 Elaine Ruth Fletcher SHARM EL SHEIKH, EGYPT – Ken Henshaw’s story of his Niger Delta community’s experience with fossil fuel extraction reads like the fallout from a war zone without the ready presence of international media to document the devastation. Henshaw lives at ground zero of one of Africa’s earliest and longest-running experiences with oil extraction, a six […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe’s ‘Dash for Gas’ in Africa is a Setback for Renewable Energy 07/11/2022 Kerry Cullinan Europe’s attempts to get alternative gas supplies from African countries in the wake of Russia’s war in Ukraine are a “bridge to nowhere”, former US vice-president Al Gore told the UN climate change talks in Egypt, COP27. “We must see the so-called dash for gas for what it really is: a dash down a bridge […] Continue reading -> Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Loss and Damage Added to Climate Agenda; WHO Calls for Fossil Fuels ‘Non-Proliferation Treaty’ 06/11/2022 Elaine Ruth Fletcher ¨Loss and damage´ from climate change gains a formal place on the COP27 agenda, as conference gets underway, while the World Health Organization issues urgent appeal to world leaders to negotiate a treaty to phase out fossil fuels altogether. Sharm el Sheikh – In a historic first, the issue of ¨loss and damage¨ finance for […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts